---
$id: https://graph.org.ai/products/commodity/51141551
$type: Product
source: UNSPSC
code: "51141551"
title: "Ciprazafone"
class: "51141500"
classTitle: "Anticonvulsants"
family: "51140000"
familyTitle: "Central nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Ciprazafone

**UNSPSC Code**: 51141551
**Class**: [Anticonvulsants](Anticonvulsants.mdx)
**Family**: [Central nervous system drugs](../Central nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an anticonvulsant agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 8RSD11181G. European Medicines Agency schedules Ciprazafone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07466MIG. Ciprazafone generally arises in the molecular formula C19H18CL2N2O2. The term CIPRAZAFONE is an International Non-Proprietary Name or INN. CIPRAZAFONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule ciprazafone under HS 29242995 and SITC 51479. As of Q4 2014, CIPRAZAFONE remains the US FDA Preferred Term for this commodity. Ciprazafone bears US NLM identifiers UMLS ID C2699233 and NCI Concept Code C78000. SMILES: CLC1CC(C(N(C(=O)CNC2CC2)C)CC1)C(=O)C1C(CL)CCCC1.

